Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gallium-68 in Medical Imaging.

Literature DB >> 27804868

Gallium-68 in Medical Imaging.

Lucia Martiniova, Louis De Palatis, Elba Etchebehere, Gregory Ravizzini¹.

Abstract

Over the past several years, Positron Emission Tomography (PET) imaging agents labeled with ;68Gallium (68Ga) have undergone a significant increase in clinical utilization. 68Ga is conveniently produced from a germanium-68/gallium-68 (68Ge/68Ga) generator. Because of the compact size and ease of use of the generator, 68Ga labeled compounds may be more cost-effective than PET radioisotopes that are cyclotron-produced. The convenient half-life of 68Ga (T1/2=68 min) provides sufficient radioactivity for various PET imaging applications, while delivering acceptable radiation doses to patients. This chapter summarizes the emerging clinical utilization of 68Ga-based radiotracers in medical imaging. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities: Chemical Species

Keywords: 68Gallium; PSMA.; generator; neuroendocrine tumors; positron emission tomography; somatostatin receptor scintigraphy

Mesh：

Substances：

Year: 2016 PMID： 27804868 DOI： 10.2174/1874471009666161028150654

Source DB: PubMed Journal: Curr Radiopharm ISSN： 1874-4710

Keyword Cloud
Cited

10 in total

1. [⁶⁸Ga]Ga-tilmanocept PET/CT lymphoscintigraphy: a novel technique for sentinel lymph node imaging.

Authors: Rutger Mahieu; Gerard C Krijger; F F Tessa Ververs; Remmert de Roos; Remco de Bree; Bart de Keizer
Journal: Eur J Nucl Med Mol Imaging Date: 2021-04 Impact factor: 9.236

2. Cyclotron-based production of ⁶⁸Ga, [⁶⁸Ga]GaCl₃, and [⁶⁸Ga]Ga-PSMA-11 from a liquid target.

Authors: Melissa E Rodnick; Carina Sollert; Daniela Stark; Mara Clark; Andrew Katsifis; Brian G Hockley; D Christian Parr; Jens Frigell; Bradford D Henderson; Monica Abghari-Gerst; Morand R Piert; Michael J Fulham; Stefan Eberl; Katherine Gagnon; Peter J H Scott
Journal: EJNMMI Radiopharm Chem Date: 2020-11-12

Review 3. Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors.

Authors: Brittany M Stopa; James Crowley; Csaba Juhász; Cara M Rogers; Mark R Witcher; Jackson W Kiser
Journal: Mol Imaging Date: 2022-04-15 Impact factor: 3.250

Review 4. The Role of [⁶⁸Ga]Ga-DOTA-SSTR PET Radiotracers in Brain Tumors: A Systematic Review of the Literature and Ongoing Clinical Trials.

Authors: Paolo Palmisciano; Gina Watanabe; Andie Conching; Christian Ogasawara; Gianluca Ferini; Othman Bin-Alamer; Ali S Haider; Maria Gabriella Sabini; Giacomo Cuttone; Sebastiano Cosentino; Massimo Ippolito; Giuseppe E Umana
Journal: Cancers (Basel) Date: 2022-06-14 Impact factor: 6.575

Review 5. Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer.

Authors: Chaninart Sakulpisuti; Putthiporn Charoenphun; Wichana Chamroonrat
Journal: Molecules Date: 2022-08-03 Impact factor: 4.927

6. Studies towards elucidating the potential of 5,10,15,20-tetrakis(p-carboxy-methyleneoxyphenyl)porphyrin as a theranostic agent for applications in PET and PDT.

Authors: Mohini Guleria; Chandan Kumar; Tapas Das; Jeyachitra Amirdhanayagam; Rohit Sharma; Haladhar D Sarma; Ashutosh Dash
Journal: Medchemcomm Date: 2018-02-12 Impact factor: 3.597

Gallium-68 in Medical Imaging.

1. [⁶⁸Ga]Ga-tilmanocept PET/CT lymphoscintigraphy: a novel technique for sentinel lymph node imaging.

2. Cyclotron-based production of ⁶⁸Ga, [⁶⁸Ga]GaCl₃, and [⁶⁸Ga]Ga-PSMA-11 from a liquid target.

Review 3. Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors.

Review 4. The Role of [⁶⁸Ga]Ga-DOTA-SSTR PET Radiotracers in Brain Tumors: A Systematic Review of the Literature and Ongoing Clinical Trials.

Review 5. Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer.

6. Studies towards elucidating the potential of 5,10,15,20-tetrakis(p-carboxy-methyleneoxyphenyl)porphyrin as a theranostic agent for applications in PET and PDT.

Review 7. Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach.

Review 8. Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors.

9. Peptide-Based ⁶⁸Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer.

10. Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules.

Gallium-68 in Medical Imaging.

1. [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy: a novel technique for sentinel lymph node imaging.

2. Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target.

Review 3. Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors.

Review 4. The Role of [68Ga]Ga-DOTA-SSTR PET Radiotracers in Brain Tumors: A Systematic Review of the Literature and Ongoing Clinical Trials.

Review 5. Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer.

6. Studies towards elucidating the potential of 5,10,15,20-tetrakis(p-carboxy-methyleneoxyphenyl)porphyrin as a theranostic agent for applications in PET and PDT.

Review 7. Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach.

Review 8. Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors.

9. Peptide-Based 68Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer.

10. Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules.

1. [⁶⁸Ga]Ga-tilmanocept PET/CT lymphoscintigraphy: a novel technique for sentinel lymph node imaging.

2. Cyclotron-based production of ⁶⁸Ga, [⁶⁸Ga]GaCl₃, and [⁶⁸Ga]Ga-PSMA-11 from a liquid target.

Review 4. The Role of [⁶⁸Ga]Ga-DOTA-SSTR PET Radiotracers in Brain Tumors: A Systematic Review of the Literature and Ongoing Clinical Trials.

9. Peptide-Based ⁶⁸Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer.